Julia Aijun Wang - 02 Dec 2024 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
Chief Financial Officer, EVP
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Julia Aijun Wang
Issuer symbol
LH
Transactions as of
02 Dec 2024
Net transactions value
$0
Form type
4
Filing time
04 Dec 2024, 10:05:22 UTC
Previous filing
03 Jul 2024
Next filing
10 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Non-qualified Stock Options Award $0 +8,100 $0.000000 8,100 02 Dec 2024 Common Stock 8,100 $240.63 Direct F1, F2
transaction LH Restricted Stock Unit Award $0 +2,680 $0.000000 2,680 02 Dec 2024 Common Stock 2,680 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
F2 The option vests in three equal annual installments beginning on the date reflected in this column.
F3 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F4 The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025.